Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with early-to-mid stage breast cancer (stage I, II, or III) confirmed by a tissue biopsy
- You are planning to receive one of two specific chemotherapy regimens (called ddAC or TC) for 4 cycles, with or without additional HER2-targeted treatment
- You have had a physical exam with your doctor within the last 4 weeks
- Your doctor considers you to be in good general health and able to carry out daily activities without significant limitations
- Your Body Mass Index (BMI) — a measure of body weight relative to height — is 19.5 or above
- You are willing to make changes to your diet and provide 3 stool (poop) samples at different points during the study
Who may not be able to join:
- Your BMI is below 19.5
- You have diabetes
- You have a history of an eating disorder
- You have a serious or poorly controlled health condition, such as kidney failure requiring dialysis, severe liver disease, uncontrolled high blood pressure, a seizure disorder, or a history of weight-loss (bariatric) surgery
- You are currently pregnant or breastfeeding
- You regularly take any of the following medications that need to be taken with food: allopurinol, aspirin, amiodarone, baclofen, bromocriptine, carvedilol, carbamazepine, cimetidine, diclofenac, doxycycline, fenofibrate, fludrocortisone, glyburide, hydrocortisone, iron supplements, ketorolac, lithium, methylprednisolone, naproxen, niacin, potassium salts, prednisone, procainamide, sevelamer, sulfasalazine, trazodone, or valproic acid (confirm with trial site if you are unsure about your medications)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jennifer Sheng, MD, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phone: 202-537-4000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of participants with self-reported adherence to the fasting regimen
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.